Preclinical data suggest that the ASM-ceramide system gets activated by SARS-CoV-2, which leads to forming of ceramide-enriched membrane domains that ease viral access and infection by arraying ACE2 (the cellular receptor of SARS-CoV-2), and the release of pro-inflammatory cytokines. Here, ACE2 is linked to infection.